Research output per year
Research output per year
Fingerprint
Dive into the research topics where Joyce Schilperoord-Vermeulen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic Leukemia
Engelmann, R., Flores-Montero, J., the EuroFlow Consortium, Schilperoord-Vermeulen, J., Ritgen, M., Hengeveld, P. J., Kohlscheen, S., Grigore, G., Rodriguez, R. F., Lecrevisse, Q., Philippé, J., Villamor, N., Fernandez, P., Burgos, L., van Dongen, J. J. M., Orfao, A., Langerak, A. W. & Böttcher, S., Apr 2025, In: American Journal of Hematology. 100, 4, p. 724-728 5 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Citations (Scopus)89 Downloads (Pure) -
Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients
Hengeveld, P. J., Schilperoord-Vermeulen, J., Kolijn, P. M., Dubois, J. M. N., Westerweel, P. E., Kersting, S., Kater, A. P., Levin, M. D. & Langerak, A. W., 7 Jan 2025, In: Blood Cancer Journal. 15, 1, 5 p., 2.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)39 Downloads (Pure) -
Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia
Hengeveld, P. J., Schilperoord-Vermeulen, J., van der Klift, M. Y., Dubois, J. M. N., Kolijn, P. M., Kavelaars, F. G., Rijken, M., Dobber, J. A., Nasserinejad, K., Kersting, S., Westerweel, P. E., Kater, A. P., Langerak, A. W. & Levin, M. D., 4 Jul 2023, In: Blood Cancer Journal. 13, 1, 102.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open AccessFile1 Citation (Scopus)82 Downloads (Pure) -
miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemia
Assmann, J. L. J. C., Leon, L. G., Stavast, C. J., van den Bogaerdt, S. E., Schilperoord-Vermeulen, J., Sandberg, Y., Bellido, M., Erkeland, S. J., Feith, D. J., Loughran, T. P. & Langerak, A. W., Apr 2022, In: Leukemia. 36, 4, p. 983-993 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile18 Citations (Scopus)75 Downloads (Pure) -
The miR-200c/141-ZEB2-TGFβ axis is aberrant in human T-cell prolymphocytic leukemia
Erkeland, S. J., Stavast, C. J., Schilperoord-Vermeulen, J., Collo, G. D., van de Werken, H. J. G., Leon, L. G., van Hoven-Beijen, A., van Zuijen, I., Mueller, Y. M., Bindels, E. M., de Ridder, D., Kappers-Klunne, M. C., van Lom, K., van der Velden, V. H. J. & Langerak, A. W., Jan 2022, In: Haematologica. 107, 1, p. 143-153 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile12 Citations (Scopus)100 Downloads (Pure)